Starpharma offers rare bright spot in market

Starpharma Holdings has finally delivered some much needed relief and shareholders will be hoping that today’s regulatory approval of its gel-coated condoms will break the stock out of its downtrend.

Starpharma Holdings (SPL) has finally delivered some much needed relief and shareholders will be hoping that today’s regulatory approval of its gel-coated condoms will break the stock out of its downtrend.

It seems to be working for now, with the stock recording its best one-session rise in six weeks of 6.9% to 78 cents at 2.30pm AEDT in a market that has crashed by over 1%.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles